Text size Data from BioNTech and Pfizer were particularly promising. Jeenah Moon / Getty Images After a hiatus from a late summer break, the news of a Covid-19 vaccine is heating up again as a handful of leading programs are rapidly moving to a decisive phase. Reports from several companies …
Read More »Tesla file is unstoppable. Here’s what could go on.
Last week, two bearish analysts finally threw in the towel on Tesla, and the stock market has not stopped running. The stock hit another $ 381 this week, up 24%, expanding its 2020 earnings to around 380%. Shares broke the $ 2,000 barrier on Thursday and, of course, rose again …
Read More »Johnson & Johnson adds debt frenzy, borrowing $ 7.5 billion to buy Momenta
The Johnson & Johnson logo is displayed outside the company’s headquarters in New Brunswick, NJ Bloomberg News Johnson & Johnson on Thursday announced their top AAA credit ratings to borrow $ 7.5 billion in cheap financing for their acquisition of Momenta Pharmaceuticals, Inc. J&J, which makes drugs, consumables and medical …
Read More »A tidal wave of news about covid vaccine is on the market
Text size Data from BioNTech and Pfizer were particularly promising. Jeenah Moon / Getty Images After a hiatus from a late summer break, the news of a Covid-19 vaccine is heating up again as a handful of leading programs are rapidly moving to a decisive phase. Reports from several companies …
Read More »Novavax stock jumps on vaccinated deal with South Korean firm
Text size Andrey Rudakov / Bloomberg Novavax said it has a deal with SK Bioscience to produce the antigen component of its Covid-19 vaccine candidate during the pandemic period. The stock jumped more than 9% Thursday morning. Novavax (ticker: NVAX) said its development and supply agreement with the South Korean …
Read More »